Skip to content
MDS: Low Risk Isn't No Risk episode artwork

Jun 30, 2026 21 min

MDS: Low Risk Isn't No Risk

from CANCER BUZZ

Myelodysplastic syndromes (MDS), a rare category of bone marrow disorders that may develop into acute myeloid leukemia, are categorized into risk groups ranging from very low to very high risk. However, this language can be misleading to patients. Low risk (LR) does not equate to low impact or lack of urgency. In this episode, CANCER BUZZ speaks with Amy DeZern, MD, MHS, from Sidney Kimmel Comprehensive Cancer Center, and Christin Blair DeStefano, MD, FACP, from Walter Reed National Military Medical Center, about the importance of aligning language and terminology regarding LR-MDS across academic and community settings. These experts candidly discuss their own collaboration and the importance of early conversations with patients to align expectations on goals, disease trajectory, and treatment sequencing. Guests: Amy DeZern, MD, MHS Hematologist/Oncologist Director, Bone Marrow Failure and MDS Program Sidney Kimmel Comprehensive Cancer Center Baltimore, MD Christin Blair DeStefano, MD, FACP Hematologist/Oncologist Walter Reed National Military Medical Center Bethesda, MD "I really try and individualize [language] to a patient and their family, because I worry that sometimes the terminology 'lower risk' may not correctly convey the impact the disease is going to have on an individual human's life." — Amy DeZern, MD, MHS "Frequent reassessment—questioning our patients about quality of life and if we're meeting the goals they have—should be something that's readily reassessed, especially in the lower risk space, every 2 to 3 months, just to make sure we don't put anybody on autopilot." — Amy De Zern, MD, MHS "There's been such an explosion in understanding the molecular landscape of MDS and slicing and dicing it into different diseases that fall under the MDS umbrella. It has sometimes created a little bit of confusion." — Christin Blair DeStefano, MD, FACP Resources: ACCC Hematologic Malignancies Resources Blood Cancer Awareness Month: Tackling Communication Challenges Addressing Frequency of Care to Improve Quality of Life in Patients with Low-Risk MDS Defining and Managing Erythropoietin Stimulating Agents (ESAs) Failure in Patients with Low-Risk MDS

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

MDS: Low Risk Isn't No Risk

0:00 21:37

No transcript yet.

Requests help us decide what to transcribe next.

Wild Virginia Old Dominion Eco Buzz Wild Virginia Wild Virginia is a 501(c)(3) nonprofit dedicated to protecting and connecting your favorite wild places. Through partnerships with other environmental advocacy groups we:We educate citizens, landowners, and other stakeholders about threats to our forests through hikes, outings and events.We advocate for the connectivity and integrity of Virginia’s forests and waters.We influence decision makers by mobilizing citizens like you. Lung Cancer Update for Nurses Dr Neil Love Featuring one-on-one interviews conducted by Dr Neil Love with national lung cancer clinical investigators and oncology nurses, this series provides practicing clinicians including nurses and nurse practitioners with valuable information and current clinical management strategies that can be applied to optimize patient care. Non-Hodgkin lymphoma – The Bloodline with LLS The Leukemia & Lymphoma Society Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis, comes hope. Listen in as we speak with experts and patients who will guide us in understanding diagnosis, treatment, and the many resources available to blood cancer patients. Lymphoma – The Bloodline with LLS The Leukemia & Lymphoma Society Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis, comes hope. Listen in as we speak with experts and patients who will guide us in understanding diagnosis, treatment, and the many resources available to blood cancer patients.

Frequently asked questions

How long is this episode of CANCER BUZZ?

This episode is 21 minutes long.

When was this CANCER BUZZ episode published?

This episode was published on June 30, 2026.

Can I download this CANCER BUZZ episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.